Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Johns Hopkins University at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Johns Hopkins University brings 19 presentations to ASH 2026 in New Orleans. Its research spans lymphoma, acute lymphoblastic leukemia and immune-mediated clotting disorders. It covers a phase 1 study of topical duvelisib in early-stage mycosis fungoides and blinatumomab in MRD-negative precursor B-cell leukemia.

OrganizationASH 2026 Attendance
Universities & research institutes
Private research university in Baltimore, Maryland, including the Johns Hopkins School of Medicine.
Symposium
Fri Dec 11
3:00pm–6:00pm
Myeloma Challenge! Test Your Knowledge of Updated Guidelines and Evidence-Based Practice
Guideline-based myeloma care from smoldering disease to late relapse, including three- or four-drug regimens, residual disease testing, and newer immunotherapies.
Symposium hosted by National Comprehensive Cancer Network and Decera Clinical Education
Myeloma
Talk
Sat Dec 12
9:30am–10:45am
Leveraging our Common African Genomes to Improve Health Globally
African genetic diversity as a driver of discovery, illustrated by sickle cell disease, kidney-risk variants, and the Duffy-null blood group.
Blood biology · Patient care

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Johns Hopkins University

Tell us what you sell and we’ll find the people at Johns Hopkins University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction